Monday
May 12, 2025
4:01 PM ET
Relmada Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Thursday
May 8, 2025
7:30 AM ET
Relmada Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025
Thursday
March 27, 2025
4:05 PM ET
Relmada Therapeutics Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Wednesday
March 26, 2025
9:00 AM ET
Relmada Therapeutics to Report Fourth Quarter 2024 Financial Results on Thursday, March 27, 2025
Wednesday
December 4, 2024
7:30 AM ET
Relmada Therapeutics Reports That Data Monitoring Committee (DMC) Assessment Indicates That the Phase 3 Reliance II Trial is Futile at its Interim Analysis and is Unlikely to Meet the Primary Efficacy Endpoint with Statistical Significance